Abstract
In this study, the effect of different CDs including α-CD, β-CD, γ-CD, hydroxypropyl β-CD (HP β-CD), sulphobutylether β-CD (SBE β-CD) and HP γ-CD on aqueous solubility of fluorometholone (Flu) was investigated. Also the phase solubility studies were performed in the presence of eye drop excipients such as benzalkonium chloride, hydroxypropyl methylcellulose (HPMC) and buffers. The aqueous solubility of Flu was increased by 8, 15, 5, 100, 65 and 135 folds in the presence of 20% w/v α-CD, β-CD, γ-CD, HP β-CD, HP γ-CD and SBE β-CD, respectively. Aqueous solubility of Flu was 0.43 ± 0.08 and 1.16 ± 0.04 mg/mL in systems containing 5% w/v HP γ-CD and SBE β-CD, respectively. The aqueous solubility of Flu in the presence of HP γ-CD was not influenced by buffer type while the phosphate buffer caused a reduction in the aqueous solubility in the presence of SBE-β-CD. Also, investigations on the solubility of Flu in water in the presence of 5% HP γ-CD and SBE-β-CD and the additives such as benzalkonium chloride and HPMC indicated that these components had no remarkable effect on the aqueous solubility of Flu. In conclusion, CD complexation is able to improve the aqueous solubility of Flu and it would be possible to prepare ophthalmic solution of Flu by this method.
Similar content being viewed by others
References
Martin Del Valle, E.M.: Cyclodextrins and their uses: a review. Process Biochem. 39, 1033–1046 (2004). doi:10.1016/S0032-9592(03)00258-9
Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3, 1023–1035 (2004). doi:10.1038/nrd1576
Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645–666 (2007). doi:10.1016/j.addr.2007.05.012
Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996). doi:10.1021/js950534b
Singla, A.K., Garg, A., Aggarwal, D.: Paclitaxel and its formulations. Int. J. Pharm. 235, 179–192 (2002). doi:10.1016/S0378-5173(01)00986-3
Spulber, M., Pinteala, M., Fifere, A., Moldoveanu, C., Mangalagiu, I., Harabagiu, V., Simionescu, B.C.: Water soluble complexes of methyl b-cyclodextrin and sulconazole nitrate. J. Incl. Phenom. Macrocycl. Chem. 62, 135–142 (2008). doi:10.1007/s10847-008-9448-y
Ohta, K., Konno, S., Endo, Y.: Complexation of b-cyclodextrin with carborane derivatives in aqueous solution. Tetrahedron Lett. 49, 6525–6528 (2008). doi:10.1016/j.tetlet.2008.08.107
Shaimaa, M., Badr-Eldin, S.M., Seham, A., Elkheshen, S.A., Mahmoud, M., Ghorab, M.M.: Inclusion complexes of tadalafil with natural and chemically modified b-cyclodextrins. I: Preparation and in vitro evaluation. Eur. J. Pharm. Biopharm. 70, 819–827 (2008). doi:10.1016/j.ejpb.2008.06.024
Larsen, K.L., Aachmann, F.L., Wimmer, R., Stella, V.J., Kjolner, U.M.: Phase solubility and structure of the inclusion complexes of prednisolone and 6a-methyl prednisolone with various cyclodextrins. J. Pharm. Sci. 94, 507–515 (2005). doi:10.1002/jps.20192
Malaekeh-Nikouei, B., Nassirli, H., Davies, N.: Enhancement of cyclosporine aqueous solubility using a- and hydroxypropyl b-cyclodextrin mixtures. J. Incl. Phenom. Macrocycl. Chem. 59, 245–250 (2007). doi:10.1007/s10847-007-9321-4
Kristinsson, J.K., Fridriksddttir, H., Thorisdottir, S., Sigurdardot, A.M.: Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Invest. Ophthalmol. Vis. Sci. 37, 1199–1203 (1996)
Friedlaender, M.: Overview of ocular allergy treatment. Curr. Allergy Asthma Rep. 1, 375–379 (2001). doi:10.1007/s11882-001-0051-1
Bielory, L., Friedlaender, M.H.: Allergic conjunctivitis. Immunol. Allergy Clin. North Am. 28, 43–58 (2008). doi:10.1016/j.iac.2007.12.005
Loftsson, T., Stefansson, E.: Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol. Scand. 80, 144–150 (2002). doi:10.1034/j.1600-0420.2002.800205.x
Loftssona, T., Jarvinen, T.: Cyclodextrins in ophthalmic drug delivery. Adv. Drug Deliv. Rev. 36, 59–79 (1999). doi:10.1016/S0169-409X(98)00055-6
Stefansson, E., Loftsson, T.: Cyclodextrins in eye drop formulations. J. Incl. Phenom. Macrocycl. Chem. 44, 23–27 (2002). doi:10.1023/A:1023015201493
Usayapant, A., Karara, A.H., Narurkar, M.M.: Effect of 2-hydroxypropyl β-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate. Pharm. Res. 8, 1495–1499 (1991). doi:10.1023/A:1015838215268
Aktaş, Y., Unlü, N., Orhan, M., Irkeç, M., Hincal, A.A.: Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine. Drug Dev. Ind. Pharm. 29, 223–230 (2003). doi:10.1081/DDC-120016730
Fridriksdottir, H., Loftsson, T., Stefansson, E.: Formulation and testing of methazolamide cyclodextrin eye drop solutions. J. Control. Release 44, 95–99 (1997). doi:10.1016/S0168-3659(96)01506-4
Higuchi, T., Connors, K.A.: Phase solubility techniques. Adv. Anal. Chem. Instrum. 4, 117–212 (1965)
Vianna, R.F.L., Bentley, M.V.B., Ribeiro, G., Neto, A.F., de Oliveira, D.C.R., Carvalho, F.S., Collett, J.H.: Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int. J. Pharm. 167, 205–213 (1998). doi:10.1016/S0378-5173(98)00068-4
Uekama, K., Fujinaga, T., Otagiri, M., Yamasaki, M.: Inclusion complexations of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharm. 10, 1–15 (1982). doi:10.1016/0378-5173(82)90057-6
Zia, V., Rajewski, R.A., Stella, V.J.: Thermodynamics of binding of natural molecules to sulfobutyl ether beta cyclodextrins: the effect of total degree of substitution. Pharm. Res. 17, 936–941 (2000). doi:10.1023/A:1007571019908
Sadlej-Sosnowska, N.: Influence of the structure of steroid hormones on their association with cyclodextrins: a high-performance liquid chromatography study. J. Incl. Phenom. Macrocycl. Chem. 27, 31–40 (1997). doi:10.1023/A:1007964116987
Loftsson, T., Matthiasson, K., Masson, M.: The effects of organic salts on the cyclodextrin solubilization of drugs. Int. J. Pharm. 262, 101–107 (2003). doi:10.1016/S0378-5173(03)00334-X
Loftsson, T., Magnudottir, A., Masson, M., Sigurjonsdottir, J.F.: Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91, 2307–2316 (2002). doi:10.1002/jps.10226
Loftsson, T.: Increasing the cyclodextrin complexation of drugs and drug bioavailability through the addition water soluble polymers. Pharmazie 53, 733–740 (1998)
Duan, M.S., Zhao, N., Ossurardottir, I.B., Thorsteinsson, T., Loftsson, T.: Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarbon: formation of aggregates and higher-order complexes. Int. J. Pharm. 297, 213–222 (2005)
Loftsson, T., Frioriksdottir, H.: The effect of water-soluble polymer on the aqueous solubility and complexing abilities of β-cyclodextrin. Int. J. Pharm. 163, 115–121 (1998). doi:10.1016/S0378-5173(97)00371-2
Loftsson, T., Masson, M.: Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm. 225, 15–30 (2001). doi:10.1016/S0378-5173(01)00761-X
Shimpi, S., Chauhan, B., Shimpi, P.: Cyclodextrins: application in different routes of drug administration. Acta Pharm. 55, 139–156 (2005)
Acknowledgment
This work was supported financially by a research grant from the Vice Chancellor for Research of Mashhad University of Medical Sciences, Mashhad, Iran.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malaekeh-Nikouei, B., Sajadi Tabassi, S.A., Ashari, H. et al. Evaluation the effect of cyclodextrin complexation on aqueous solubility of fluorometholone to achieve ophthalmic solution. J Incl Phenom Macrocycl Chem 65, 335–340 (2009). https://doi.org/10.1007/s10847-009-9590-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-009-9590-1